Authors:
Van Waes, C
Enamorado-Ayala, I
Hecht, D
Sulica, L
Chen, Z
Batt, DG
Mousa, S
Citation: C. Van Waes et al., Effects of the novel alpha(v) integrin antagonist SM256 and cis-platinum on growth of murine squamous cell carcinoma PAM LY8, INT J ONCOL, 16(6), 2000, pp. 1189-1195
Citation: Dg. Batt et al., Synthesis of cis and trans isomers of an isoxazoline ring-hydroxylated metabolite of Roxifiban, a platelet glycoprotein IIb/IIIa receptor antagonist, J ORG CHEM, 65(23), 2000, pp. 8100-8104
Authors:
Pinto, DJP
Batt, DG
Pitts, WJ
Petraitis, JJ
Orwat, MJ
Wang, SG
Jetter, JW
Sherk, SR
Houghton, GC
Copeland, RA
Covington, MB
Trzaskos, JM
Magolda, RL
Citation: Djp. Pinto et al., Terphenyl cyclooxygenase-2 (COX-2) inhibitors: Optimization of the centralring and o-biphenyl analogs, BIOORG MED, 9(7), 1999, pp. 919-924
Authors:
Rockwell, AL
Rafalski, M
Pitts, WJ
Batt, DG
Petraitis, JJ
DeGrado, WF
Mousa, S
Jadhav, PK
Citation: Al. Rockwell et al., Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase:Identification of alpha v beta 3 antagonists lead compounds, BIOORG MED, 9(7), 1999, pp. 937-942
Authors:
Mousa, SA
Lorelli, W
Mohamed, S
Batt, DG
Jadhav, PK
Reilly, TM
Citation: Sa. Mousa et al., alpha(v)beta(3) integrin binding affinity and specificity of SM256 in various species, J CARDIO PH, 33(4), 1999, pp. 641-646
Authors:
Olson, RE
Sielecki, TM
Wityak, J
Pinto, DJ
Batt, DG
Frietze, WE
Liu, J
Tobin, AE
Orwat, MJ
Di Meo, SV
Houghton, GC
Lalka, GK
Mousa, SA
Racanelli, AL
Hausner, EA
Kapil, RP
Rabel, HR
Thoolen, MJ
Reilly, TM
Anderson, PS
Wexler, RR
Citation: Re. Olson et al., Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action, J MED CHEM, 42(7), 1999, pp. 1178-1192